Baird Medical Investment Net Income
| BDMD Stock | 0.77 0.03 3.75% |
As of the 15th of February 2026, Baird Medical shows the Risk Adjusted Performance of (0.11), standard deviation of 4.36, and Mean Deviation of 3.11. Baird Medical Investment technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Baird Medical Investment information ratio, as well as the relationship between the value at risk and kurtosis to decide if Baird Medical Investment is priced correctly, providing market reflects its regular price of 0.77 per share. As Baird Medical Investment is a penny stock we also strongly suggest to validate its jensen alpha numbers.
Baird Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.5276 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 14.5 M | 8.4 M | |
| Net Income From Continuing Ops | 14.5 M | 12.7 M | |
| Net Income Per Share | 0.44 | 0.74 | |
| Net Income Per E B T | 1.02 | 1.01 |
Baird | Net Income | Build AI portfolio with Baird Stock |
Analyzing Baird Medical's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Baird Medical's current valuation and future prospects.
Latest Baird Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Baird Medical Investment over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Baird Medical Investment financial statement analysis. It represents the amount of money remaining after all of Baird Medical Investment operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Baird Medical's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Baird Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 12.6 M | 10 Years Trend |
|
Net Income |
| Timeline |
Baird Net Income Regression Statistics
| Arithmetic Mean | 321,944 | |
| Geometric Mean | 8,491,433 | |
| Coefficient Of Variation | 2,911 | |
| Mean Deviation | 8,830,441 | |
| Median | (7,183,931) | |
| Standard Deviation | 9,371,556 | |
| Sample Variance | 87.8T | |
| Range | 21.5M | |
| R-Value | 0.86 | |
| Mean Square Error | 25.1T | |
| R-Squared | 0.73 | |
| Significance | 0.000012 | |
| Slope | 1,587,774 | |
| Total Sum of Squares | 1405.2T |
Baird Net Income History
Other Fundumenentals of Baird Medical Investment
Baird Medical Net Income component correlations
Baird Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Baird Medical is extremely important. It helps to project a fair market value of Baird Stock properly, considering its historical fundamentals such as Net Income. Since Baird Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Baird Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Baird Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Health Care Equipment & Supplies sector continue expanding? Could Baird diversify its offerings? Factors like these will boost the valuation of Baird Medical. Projected growth potential of Baird fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Baird Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0) | Earnings Share (0.11) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets |
Baird Medical Investment's market price often diverges from its book value, the accounting figure shown on Baird's balance sheet. Smart investors calculate Baird Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Baird Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Baird Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Baird Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Baird Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Baird Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Baird Medical.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Baird Medical on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Baird Medical Investment or generate 0.0% return on investment in Baird Medical over 90 days. Baird Medical is related to or competes with Icecure Medical, Cytosorbents Crp, Neuroone Medical, Heartbeam, Electrocore LLC, Vicarious Surgical, and Inotiv. Baird Medical is entity of United States More
Baird Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Baird Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Baird Medical Investment upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 21.01 | |||
| Value At Risk | (8.00) | |||
| Potential Upside | 8.67 |
Baird Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Baird Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Baird Medical's standard deviation. In reality, there are many statistical measures that can use Baird Medical historical prices to predict the future Baird Medical's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.67) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | (6.28) |
Baird Medical February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (6.27) | |||
| Mean Deviation | 3.11 | |||
| Coefficient Of Variation | (670.37) | |||
| Standard Deviation | 4.36 | |||
| Variance | 19.0 | |||
| Information Ratio | (0.17) | |||
| Jensen Alpha | (0.67) | |||
| Total Risk Alpha | (0.98) | |||
| Treynor Ratio | (6.28) | |||
| Maximum Drawdown | 21.01 | |||
| Value At Risk | (8.00) | |||
| Potential Upside | 8.67 | |||
| Skewness | 0.4961 | |||
| Kurtosis | 1.01 |
Baird Medical Investment Backtested Returns
Baird Medical Investment secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16 % return per unit of risk over the last 3 months. Baird Medical Investment exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Baird Medical's Risk Adjusted Performance of (0.11), standard deviation of 4.36, and Mean Deviation of 3.11 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.11, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Baird Medical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Baird Medical is expected to be smaller as well. At this point, Baird Medical Investment has a negative expected return of -0.73%. Please make sure to confirm Baird Medical's total risk alpha, kurtosis, market facilitation index, as well as the relationship between the value at risk and rate of daily change , to decide if Baird Medical Investment performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.17 |
Very weak predictability
Baird Medical Investment has very weak predictability. Overlapping area represents the amount of predictability between Baird Medical time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Baird Medical Investment price movement. The serial correlation of 0.17 indicates that over 17.0% of current Baird Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.17 | |
| Spearman Rank Test | 0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Baird Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Baird Medical Investment reported net income of 12.6 M. This is 96.31% lower than that of the Health Care Equipment & Supplies sector and 94.71% lower than that of the Health Care industry. The net income for all United States stocks is 97.79% higher than that of the company.
Baird Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Baird Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Baird Medical could also be used in its relative valuation, which is a method of valuing Baird Medical by comparing valuation metrics of similar companies.Baird Medical is currently under evaluation in net income category among its peers.
Baird Fundamentals
| Return On Equity | -0.0803 | ||||
| Return On Asset | -0.002 | ||||
| Profit Margin | (0.1) % | ||||
| Operating Margin | (1.31) % | ||||
| Current Valuation | 48.67 M | ||||
| Shares Outstanding | 36.73 M | ||||
| Shares Owned By Insiders | 69.52 % | ||||
| Shares Owned By Institutions | 1.13 % | ||||
| Number Of Shares Shorted | 37.63 K | ||||
| Price To Book | 0.79 X | ||||
| Price To Sales | 0.89 X | ||||
| Revenue | 37.04 M | ||||
| Gross Profit | 27.7 M | ||||
| EBITDA | 16.17 M | ||||
| Net Income | 12.6 M | ||||
| Total Debt | 20.88 M | ||||
| Book Value Per Share | 1.34 X | ||||
| Cash Flow From Operations | (6.31 M) | ||||
| Short Ratio | 0.29 X | ||||
| Earnings Per Share | (0.11) X | ||||
| Number Of Employees | 143 | ||||
| Beta | -1.08 | ||||
| Market Capitalization | 28.28 M | ||||
| Total Asset | 77.96 M | ||||
| Retained Earnings | 26.76 M | ||||
| Working Capital | 26.79 M | ||||
| Net Asset | 77.96 M |
About Baird Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Baird Medical Investment's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baird Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baird Medical Investment based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Baird Medical Investment is a strong investment it is important to analyze Baird Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Baird Medical's future performance. For an informed investment choice regarding Baird Stock, refer to the following important reports:Check out You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Will Health Care Equipment & Supplies sector continue expanding? Could Baird diversify its offerings? Factors like these will boost the valuation of Baird Medical. Projected growth potential of Baird fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Baird Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0) | Earnings Share (0.11) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets |
Baird Medical Investment's market price often diverges from its book value, the accounting figure shown on Baird's balance sheet. Smart investors calculate Baird Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Baird Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Baird Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Baird Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Baird Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.